SPRYT’s Post

CancerX Moonshot joins forces with KidsX and expand into #AI in cancer care   🏛 CancerX is The White House-sponsored public-private partnership that acts as a national accelerator to boost innovation in the fight against cancer.   🚀 The team announced in October the launch of its 2025 Acceleration program, valuing a successful inaugural cohort. The focus for next year includes “transforming digital innovation and AI solutions in cancer care”.   🧒 CancerX has also announced a partnership together with KidsX, a community of pediatric hospitals. Through this collaboration, the goal is to provide a place for innovative start-ups to fuel this vital and neglected area.   📈 There are more than 2 million cases of cancer predicted for 2024 in the United States, and more than 600,000 deaths.   📌 Check out the sources and the application details in the links in first comment! #cancer #digitalhealth #oncology

🚨 Unlocking Insights from the Cambridge Barrett's Registry 🚨 At Heartburn Cancer UK, we’re thrilled to share the latest insights from the Cambridge Barrett’s Registry, a crucial initiative in understanding Barrett’s oesophagus and its link to oesophageal cancer. These insights were recently discussed at our event ‘Caring for Patients with Heartburn & Barrett’s oesophagus’ by Dr. Massimiliano Di Pietro, a leading expert in the field. The discussion highlighted how the registry plays a pivotal role in early detection and better patient outcomes. 🔍 Key Takeaways: ❤️🔥 The importance of early detection in managing Barrett’s oesophagus. 🔬How the Cambridge Barrett’s Registry is shaping research and treatment for oesophageal cancer. ❤️🔥 The significance of community involvement in improving long-term outcomes. 💡 Knowledge is power – and this research can save lives. Catch up on the details from the event and explore more about the Cambridge Barrett’s Registry and its impact on oesophageal cancer research over on our blog: 👉 https://lnkd.in/euSwTPUv #HeartburnCancerUK #oesophagealcancer #Barrettsoesophagus #cancerresearch

IOZK Innovation Show Case Presentation on 01.10.2024, 15:00 CET, Stefaan Van Gool, MD. PhD. Join our Live-Webinar at the zoom link: https://lnkd.in/egEqTzFc IOZK is a sponsor of this year's World Cancer Series which was planned to take place on 30.09/1.10 in Brussels, but was recently cancelled. Dr. Van Gool planned to present our Innovation showcase for Improving outcomes and improving value in Cancer Care. We are presenting it to you in the virtual environment. The Innovation Show Cases highlights technologies that are designed to improve the value of cancer care. Dr. Van Gool will answer three questions: 1) What are the innovative aspects of their technology or service design, and how are they intended to improve efficiency and value? 2) How has it been put into use? 3) What has been the demonstrable impact? "Since each cancer in each patient is different, and changing over time, different kinds of immunotherapy should be included, right from the beginning, in all consecutive treatment combinations. Only then, we might reach prolonged control over the cancer." #worldcancerserieseurope #WorldCancerSeries #Immunotherapy #fightcancer

In my role as a federal health management consultant, I witness the collaboration between federal agencies delivering cancer care. But even more inspiring are the stories of patients, families, caregivers, and advocates whose lives have been impacted by government investment in cancer research across all stages. #cancer #innovation #research

April is National Cancer Control Month, a time dedicated to raising awareness about cancer prevention, early detection, and research towards finding a cure. Research shows that up to 50% of cancer cases and about 50% of cancer deaths are preventable, with strategies focused on prevention, early detection, and effective treatments. In this National Cancer Control Month, we at the National Foundation for Cancer Research (NFCR) encourage you to take proactive steps in the fight against cancer. Here are ways you can contribute: 1. Educate yourself and others about cancer prevention and early detection 2. Advocate for policies supporting cancer research and patient care 3. Volunteer with organizations that support cancer patients and research 4. Donate to support groundbreaking cancer research This National Cancer Control Month, we're not just celebrating progress; we're accelerating it. Join NFCR in this mission and turn hope into action! Visit our website at www.nfcr.org to learn more about cancer and get involved in making cures possible! https://lnkd.in/egA25rnh #nationalcancercontrolmonth #cancermoonshot #makecurespossible #cancerresearch #collaboration #innovation #cancertreatment #cancersupport #NFCR 

On this Rare Cancer Day, We’re announcing that we will be launching the first patient-powered data commons! Anyone with a rare cancer will soon be able to donate their medical records and sequencing data to a secure online platform. RCRF’s Pattern Data Commons will: -Allow patients to consent to RCRF collecting their medical records and sequencing data through a secure online portal -Match patients’ data with ongoing RCRF research projects and enable patients to choose how their data helps researchers study rare cancers -Share the de-identified and harmonized data with the research community to accelerate discovery and progress We encourage people with rare cancers to #DonateYourData through this patient-powered initiative which aims to accelerate discovery of new treatments and ensure patients are at the center of research. Sign up to be alerted when the Pattern Data Commons launches at https://lnkd.in/ehGeByrV. Learn more about the Rare Cancer Research Foundation at rarecancer.org

World Lung Cancer Day with BABVIP Developers At Bavvip Developers, we're committed to creating a healthier and more informed world. On this World Lung Cancer Day, we're joining the global effort to raise awareness about lung cancer, a disease that affects millions every year. Did You Know? Lung cancer is the most common cancer worldwide, with over 2 million new cases annually. Early detection can significantly improve survival rates. As tech innovators, we believe in using our skills for the greater good. Let's harness the power of technology to: Spread awareness about the importance of early detection. Support research and healthcare initiatives. Join us in the fight against lung cancer. Share your stories, encourage early screenings, and help us spread the word. Together, we can make a difference, one breath at a time. #WorldLungCancerDay #BabvipDevelopers #LungCancerAwareness #TechForHealth #EveryBreathCounts

The Annual Knæk Cancer Weeks: Highlighting Progress and Inspiring Stories in the Fight Against Cancer 🌸 Supporting Cancer Research: Every Step Counts 🌸 We are proud to support the annual Knæk Cancer Awareness Week in Denmark. At AnRes Clinical, our commitment to advancing clinical research is at the heart of what we do every day. By contributing to national fundraising efforts, we aim to ensure even more groundbreaking research and better outcomes for cancer patients. We have all been touched by cancer in some way. We feel deep empathy and understanding for those who are battling the disease, those who have lost loved ones, and those who are currently in the eye of the storm, uncertain of what the future holds. Together, we can make a difference. Let’s continue to push the boundaries of science and support those affected by cancer. 💪💖 #KnækCancer #CancerResearch #ClinicalStudies #SupportResearch #TogetherWeCan

This week, as we acknowledge Rare Cancer Awareness Day, I'm honored to share that our work on Metastatic Breast Cancer (MBC) and co-design has been accepted at MASCC in France 🇫🇷 . I'll be presenting tomorrow on the Power of Patient Advocacy – Making Metastatic Breast Cancer Count, while also showcasing through the Innovation stream our poster on the value of co-design in understanding patient experiences. Bringing awareness to the challenges faced by those with cancer and even moreso rare cancers is crucial. These challenges include high out-of-pocket expenses, limited information and support, restricted treatment options, less research and investment, and late diagnosis. Data is crucial if we are to improve outcomes for those diagnosed and living with rare cancers. #RareCancerAwareness #MetastaticBreastCancer #PatientAdvocacy #MASCC #Innovation #HealthcareResearch Breast Cancer Network Australia Rare Cancers Australia Sam Mills Siobhan Dunne Erana Boyd Kirsten Pilatti The Multinational Association of Supportive Care in Cancer (MASCC)